| Name | 2-Chloro-N6-cyclopentyl Adenosine |
|---|---|
| Synonyms |
N-Cyclopentyl-2-chloroadenosine
2 Chloro N6 cyclopentyladenosine,2ChloroN6cyclopentyladenosine,2-Chloro-N-6-cyclopentyladenosine (2R,3R,4S,5R)-2-[2-Chloro-6-(cyclopentylamino)-9H-purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol CA, 10 mM in DMSO 2-CHLORO-N6-CYCLOPENTYLADENOSINE (CA) A1 ADENOSINE RECTOR 2-CHLORO-N6-CYCLOPENTYLADENOSINE 2-Chloro-N6-cyclopentyladenosine (CA), A1 agonist 2-chloro-Ncyclopentyladenosine|||2-CHLORO-N-CYCLOPENTYLADENOSINE 2-Chloro-N≤sup>=6≤/sup>=-cyclopentyladenosine 2-Chloro-N-cyclopentyladenosine 2-chloro-N(sup 6)-cyclopentyladenosine 2-Chloro-N-cyclop CA //BP 2-chloro-n-cyclopentyl-adenosin 2-Chloro-N6-cyclopentyladenosine (CA), min 2-Chloro-N6-cyclopentyladenosine hemihydrate 2-Chloro-N6-cyclopentyladenosine 2-CHLORO-N-CYCLOPENTYLADENOSINE 2-Chloro-N6-cyclopentyladenosine 2-Chloro-N6-cyclopentyladenosine Adenosine, 2-chloro-N-cyclopentyl 2-Chloro-N6-cyclopentyladenosine,2-Chloro-N-cyclopentyladenosine |
| Description | CCPA (2-Chloro-N6-cyclopentyladenosine) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.87g/cm3 |
|---|---|
| Boiling Point | 617.3ºC at 760mmHg |
| Molecular Formula | C15H20ClN5O4 |
| Molecular Weight | 369.80 |
| Flash Point | 327.1ºC |
| Exact Mass | 369.12000 |
| PSA | 125.55000 |
| LogP | 0.51870 |
| Index of Refraction | 1.824 |
| Storage condition | 2-8°C |
| Water Solubility | H2O: 1.7 mg/mL, insoluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | 24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | AU7357555 |
| Precursor 3 | |
|---|---|
| DownStream 1 | |